Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Haemophilus influenzae adhesins are a family of bacterial outer membrane proteins that mediate specific adherence of H. influenzae to human epithelial cells, a key step in colonization and pathogenesis. Major adhesins include Protein E (PE), Hia, Hsf, and Hap. - **Protein E (PE):** Multifunctional; binds plasminogen, laminin, and vitronectin through defined surface-exposed regions; dimeric structure resembling a flattened β-barrel with immunogenic surface loops[1][5]. - **Hia:** Trimeric autotransporter present in nontypeable strains; contains two main binding domains (HiaBD1, HiaBD2) that interact with the same, as-yet-unidentified host receptor; mediates strong epithelial adhesion[2][6][7]. - **Hsf:** Large trimeric autotransporter in encapsulated (type b) strains; extended architecture allowing protrusion beyond the capsule; possesses multiple binding domains (HsfBD1, HsfBD2) homologous to those of Hia and required for binding to host cells[2][6]. - **Hap:** Self-associating and serine protease autotransporter; also implicated in adhesion and aggregation[3][6]. Collectively, these adhesins are considered key virulence factors and attractive vaccine or therapeutic targets for inhibiting H. influenzae colonization and infection[2][6]. However, the term "Haemophilus influenzae adhesins" describes a class rather than a single canonical molecule, and more specific nomenclature (e.g., "Haemophilus influenzae protein E") should be used in structured datasets[1][2][6].
For potential therapeutics, the main mechanism is inhibition of bacterial adhesion by blocking specific binding domains or eliciting an immune response (e.g., neutralizing antibodies targeting adhesive epitopes)[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Haemophilus influenzae adhesin (null).